Erratum to: Support Care Cancer
DOI 10.1007/s00520-017-3746-0
Tables 2 and 3 are incorrect in the initially published version. The correct Tables 2 and 3 are presented in this paper and the original article was corrected.
Table 2.
Impact of Severe Fatigue on Quality of Life of AYAs with cancer
| Non-severely fatigued patients (n = 43) | Severely fatigued patients (n = 40) | |||
|---|---|---|---|---|
| QoL-CS | Mean (SD) | Mean (SD) | Mean difference | Sig. |
| Physical well-being | 8.28 (1.21) | 6.57 (1.49) | −1.71 | .000** |
| Social well-being | 5.41 (1.33) | 4.81 (1.30) | −0.60 | .042* |
| Psychological well-being | 6.27 (1.29) | 4.90 (1.59) | −1.37 | .000** |
| Spiritual well-being | 4.21 (1.16) | 3.29 (1.36) | −0.92 | .001** |
| Total QoL | 6.12 (0.82) | 4.95 (1.13) | −1.17 | .000** |
*Mean difference is significant at the 0.05 level. **Mean difference is significant at the 0.01 level.
Table 3.
Correlates of Fatigue Severity in AYAs with cancer
| Correlation coefficients | No. | Sig. | |
|---|---|---|---|
| Sociodemographic variables | |||
| Age at cancer diagnosis | .194 | 83 | .079 |
| Age at participation | .185 | 83 | .093 |
| Gender (male/female) | .336 | 83 | .002** |
| Partner status (yes/no) | .118 | 82 | .291 |
| Children (yes/no) | −.122 | 82 | .273 |
| Employed or studying (yes/no) | .394 | 79 | .000** |
| Disease and treatment-related variables | |||
| Time since cancer diagnosis | .073 | 83 | .513 |
| Cancer stage at diagnosis (early/late)a | .322 | 67 | .008* |
| Duration of cancer treatment | .087 | 81 | .439 |
| Cancer treatment at participation (yes/no) | −.227 | 83 | .039* |
| Time since completion of cancer treatment | .060 | 61 | .646 |
| Intent of cancer treatment (curative/palliative) | .270 | 83 | .013* |
| Surgery (yes/no) | .178 | 83 | .108 |
| Chemotherapy (yes/no) | .115 | 83 | .302 |
| Radiotherapy (yes/no) | −.242 | 83 | .028* |
| Immuno- or targeted therapy (yes/no) | −.107 | 83 | .336 |
| Hormone therapy (yes/no) | .064 | 83 | .563 |
| Psychological variables | |||
| Psychological distress (HADS total) | .553 | 83 | .000** |
| Fear of recurrence or progression (CWS total)b | .340 | 71 | .004** |
*Correlation is significant at the 0.05 level. **Correlation is significant at the 0.01 level.
aCancer stage was unknown for n = 7 AYAs with cancer and not applicable for n = 9 AYAs with cancer.
bCWS was not administered to n = 12 AYAs with cancer, because they either had a recurrence (n = 5) or received treatment with palliative intent (n = 7).
Footnotes
The online version of the original article can be found at doi: 10.1007/s00520-017-3746-0